Cornerstone Capital Management Holdings’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
Other funds holding ARIA
Cornerstone Capital Management Holdings's ARIA Position: Q1 2017 in Review
Cornerstone Capital Management Holdings sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 33,617 shares — an estimated $418K sold.
Cornerstone Capital Management Holdings first reported a position in ARIA in Q3 2014 and held it in 10 quarters. The position peaked at $456K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Cornerstone Capital Management Holdings reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Cornerstone Capital Management Holdings sold 33,617 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $418K.
- Cornerstone Capital Management Holdings first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 10 quarters.
- Cornerstone Capital Management Holdings's Ariad Pharmaceuticals Inc position peaked at $456K in Q3 2016.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2017, filed 10 May 2017.